Inhaltsbereich
| 140 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
 Druckansicht
|
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. |
| Peters C, Schrappe M, von Stackelberg A, Schrauder A, Bader P, Ebell W, Lang P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Meisel R, Matthes-Martin S, Gungor T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Poetschger U, Zimmermann M, Klingebiel T |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Mar 9. pii: JCO.2014.58.9747. doi: 10.1200/JCO.2014.58.9747 |
| PMID: 25753432 |
| Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial. |
| Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, Stachel D, Schrappe M, Alten J, Schrauder A, Schulz A, Lang P, Müller I, Albert MH, Willasch AM, Klingebiel TE, Peters C |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Jan 20. pii: JCO.2014.58.4631. doi: 10.1200/JCO.2014.58.4631 |
| PMID: 25605857 |
| Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. |
| Goldinger SM, Zimmer L, Schulz C, Ugurel S, Hoeller C, Kaehler KC, Schadendorf D, Hassel JC, Becker J, Hauschild A, Dummer R |
| European journal of cancer (Oxford, England : 1990). 2013 Oct 29. pii: S0959-8049(13)00876-9. doi: 10.1016/j.ejca.2013.09.014 |
| PMID: 24183461 |
| Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients. |
| Kirchheiner K, Nout R, Lindegaard J, Petrič P, Limbergen EV, Jürgenliemk-Schulz IM, Haie-Meder C, Pötter R, Dörr W |
| Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. 2012 Aug 17. doi: 10.1007/s00066-012-0156-6 |
| PMID: 22895624 |
| Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma. |
| Kornek G, Raderer M, Schenk T, Pidlich J, Schulz F, Globits S, Tetzner C, Scheithauer W |
| Cancer. 1996 Jun 20. |
| PMID: 8620409 |
| A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach. |
| Kornek G, Schulz F, Depisch D, Rosen H, Kwasny W, Sebesta C, Scheithauer W |
| Cancer. 1993 Apr 20. |
| PMID: 8453539 |
| Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy. |
| Valent P, Sillaber C, Geissler K, Andreeff M, Tafuri A, Vieder L, Schulz G, Lechner K, Bettelheim P |
| Cancer investigation. 1993 May 4. |
| PMID: 8462024 |
| Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts. |
| Valent P, Sillaber C, Geissler K, Andreeff M, Tafuri A, Vieder L, Schulz G, Lechner K, Bettelheim P |
| Medical and pediatric oncology. Supplement. 1993 Aug 19. |
| PMID: 1306881 |
| Immediate graft function after OLT clears endotoxins. |
| Steininger R, Függer R, Hackl W, Hamilton G, Längle F, Herbst F, Gnant M, Sautner T, Rogy M, Schulz F |
| Transplantation proceedings. 1990 Sep 26. |
| PMID: 2389396 |
| GM-CSF in combination with cytotoxic chemotherapy in AML patients. |
| Bettelheim P, Muhm M, Valent P, Geissler K, Andreeff M, Haimi J, Sillaber C, Hinterberger W, Vieder L, Schulz G |
| Bone marrow transplantation. 1990 Oct 4. |
| PMID: 2202464 |
| Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. |
| Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, Jürgenliemk-Schulz IM, Hoskin PJ, Rai B, Dörr W, Kirisits C, Bentzen SM, Pötter R, Tanderup K |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Jan 9. pii: S0167-8140(16)00002-5. doi: 10.1016/j.radonc.2015.12.025 |
| PMID: 26780997 |
| Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE). |
| Yoshida K, Jastaniyah N, Sturdza A, Lindegaard J, Segedin B, Mahantshetty U, Rai B, Jürgenliemk-Schulz I, Haie-Meder C, Sasaki R, Pötter R |
| International journal of radiation oncology, biology, physics. 2015 Aug 7. pii: S0360-3016(15)03120-X. doi: 10.1016/j.ijrobp.2015.08.007 |
| PMID: 26530747 |
| Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run. |
| Kirisits C, Federico M, Nkiwane K, Fidarova E, Jürgenliemk-Schulz I, de Leeuw A, Lindegaard J, Pötter R, Tanderup K |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2015 Aug 24. pii: S0167-8140(15)00407-7. doi: 10.1016/j.radonc.2015.08.001 |
| PMID: 26316396 |
| Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia. |
| Preuner S, Peters C, Pötschger U, Daxberger H, Fritsch G, Geyeregger R, Schrauder A, von Stackelberg A, Schrappe M, Bader P, Ebell W, Eckert C, Lang P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Meisel R, Lawitschka A, Mann G, Panzer-Grümayer R, Güngör T, Holter W, Strahm B, Gruhn B, Schulz A, Woessmann W, Lion T |
| Haematologica. 2016 Feb 11. pii: haematol.2015.135137. doi: 10.3324/haematol.2015.135137 |
| PMID: 26869631 |
| Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study. |
| Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA |
| International journal of radiation oncology, biology, physics. 2015 Dec 29. pii: S0360-3016(15)27202-1. doi: 10.1016/j.ijrobp.2015.12.363 |
| PMID: 26876955 |
| Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. |
| Sturdza A, Pötter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, Petric P, Šegedin B, Jurgenliemk-Schulz IM, Nomden C, Gillham C, McArdle O, Van Limbergen E, Janssen H, Hoskin P, Lowe G, Tharavichitkul E, Villafranca E, Mahantshetty U, Georg P, Kirchheiner K, Kirisits C, Tanderup K, Lindegaard JC |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Apr 29. pii: S0167-8140(16)31018-0. doi: 10.1016/j.radonc.2016.03.011 |
| PMID: 27134181 |
| CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). |
| Michl M, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmueller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Mueller S, Lerch MM, Modest DP, Kirchner T, Jung A, Heinemann V |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 May 27. pii: mdw222. doi: 10.1093/annonc/mdw222 |
| PMID: 27234640 |
| Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. |
| Mohamed S, Lindegaard JC, de Leeuw AA, Jürgenliemk-Schulz I, Kirchheiner K, Kirisits C, Pötter R, Tanderup K |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Jun 3. pii: S0167-8140(16)31123-9. doi: 10.1016/j.radonc.2016.05.020 |
| PMID: 27267048 |
| Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. |
| Tanderup K, Fokdal LU, Sturdza A, Haie-Meder C, Mazeron R, van Limbergen E, Jürgenliemk-Schulz I, Petric P, Hoskin P, Dörr W, Bentzen SM, Kirisits C, Lindegaard JC, Pötter R |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Jun 24. pii: S0167-8140(16)31117-3. doi: 10.1016/j.radonc.2016.05.014 |
| PMID: 27350396 |
| 140 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
